Results 11 to 20 of about 106,790 (296)
Antipsychotics and dementia [PDF]
BMC Geriatrics, 2010 Background In recent years use of antipsychotics was widely debated for concerns about their safety in elderly patients affected with dementia [1,2].
G. De Sarro +6 more
openaire +3 more sources
Pharmacogenetics of Antipsychotics [PDF]
The Canadian Journal of Psychiatry, 2014 Objective: During the past decades, increasing efforts have been invested in studies to unravel the influence of genetic factors on antipsychotic (AP) dosage, treatment response, and occurrence of adverse effects. These studies aimed to improve clinical care by predicting outcome of treatment with APs and thus allowing for individualized treatment ...
Eva J. Brandl +2 more
openaire +3 more sources
Risperidone-induced tardive akathisia: A rare antipsychotic side effect with management issues
Annals of Indian Academy of Neurology, 2019 Akathisia is a movement disorder, a common extrapyramidal side effect that has been reported to occur primarily with antipsychotics and some neurological conditions.
Biswa Ranjan Mishra +3 more
doaj +1 more source
Association Study of the Complement Component C4 Gene in Tardive Dyskinesia
Frontiers in Pharmacology, 2019 Tardive dyskinesia (TD) is a movement disorder that may develop in schizophrenia patients being treated long-term with antipsychotic medication. TD interferes with voluntary movements and leads to stigma, and can be associated with treatment non ...
Clement C. Zai +30 more
doaj +1 more source
Antipsychotics and Amotivation [PDF]
Neuropsychopharmacology, 2015 Antipsychotic drugs are thought to produce secondary negative symptoms, which can also exacerbate primary negative symptoms. In the present study, we examined whether motivational deficits in particular were related to antipsychotic treatment in patients with schizophrenia in a dose-dependent manner.
Hiroyoshi Takeuchi +6 more
openaire +3 more sources
Pharmacology Research & Perspectives, 2020 α1‐adrenoceptor antagonists are widely used for hypertension (eg, doxazosin) and benign prostatic hypertrophy (BPH, eg, tamsulosin). Some antidepressants and antipsychotics have been reported to have α1 affinity.
Richard G. W. Proudman +2 more
doaj +1 more source
Frontiers in Neuroscience, 2020 Objective: Antipsychotic medication non-adherence has detrimental effects on patients' clinical outcome. It is unclear which risk factors affect adherence most and which interventions are effective at improving adherence to antipsychotic medication.
Kawtar El Abdellati +5 more
doaj +1 more source
Frontiers in Neuroscience, 2022 Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and one of the leading indications for liver transplantation.
Anwesha Gangopadhyay +4 more
doaj +1 more source
Frontiers in Psychiatry, 2014 Psychotic disorders most commonly appear during the late teenage years and early adulthood. A focused and rapid clinical response by an integrated health team can help to improve the quality of life of the patient, leading to a better long-term prognosis.
Diane H. Fredrikson +7 more
doaj +1 more source
Pharmacology Research & Perspectives, 2022 α2‐Adrenoceptors, subdivided into α2A, α2B, and α2C subtypes and expressed in heart, blood vessels, kidney, platelets and brain, are important for blood pressure, sedation, analgesia, and platelet aggregation.
Richard G.W. Proudman +2 more
doaj +1 more source